KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q3 2021 Results - Earnings Call Transcript
Karyopharm Therapeutics Inc. (KPTI) Q3 2021 Earnings Conference Call November 03, 2021 08:30 AM ET Company Participants Jason Finkelstein - Argot Partners Richard Paulson - President & Chief Executive Officer Sohanya Cheng - Senior Vice President-Sales & Commercial Operations Jatin Shah - Chief Medical Officer Mike Mason - Chief Financial Officer Stephen Mitchener - Chief Business Officer Sharon Shacham - Chief Scientific Officer Conference Call Participants Mauri Raycroft - Jeffries Peter Lawson - Barclays David Lebowitz - Morgan Stanley Jonathan Chang - SVB Leerink Colleen Kusy - Baird Presentation Operator Good morning. My name is [indiscernible], and I will be your conference operator today. At this time, I’d like to welcome everyone to the Karyopharm Therapeutics' Third Quarter 2021 Financial Results Conference Call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request. I would now like to turn
For further details see:
Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q3 2021 Results - Earnings Call Transcript